Correlation Between Caribou Biosciences and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and X4 Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and X4 Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and X4 Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Caribou and XFOR is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and X4 Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.36 times more return on investment than X4 Pharmaceuticals. However, Caribou Biosciences is 2.76 times less risky than X4 Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 188.00 in Caribou Biosciences on August 29, 2024 and sell it today you would earn a total of 14.00 from holding Caribou Biosciences or generate 7.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Caribou Biosciences |
| X4 Pharmaceuticals |
Caribou Biosciences and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and X4 Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Caribou Biosciences vs. Eliem Therapeutics | Caribou Biosciences vs. Scpharmaceuticals | Caribou Biosciences vs. Milestone Pharmaceuticals | Caribou Biosciences vs. Seres Therapeutics |
| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals | X4 Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |